About

MyHabeats is a mobile app that uses the power of behavioral science to help patients who undergo bariatric and metabolic surgery adopt new healthy eating habits and change lifestyle habits that last. It acts as a behavioral vaccine app since it immunizes patients ( vulnerable and marginalized ) against recurring old habits which led to obesity. MyHabeats is the first behavioral vaccine ( a meaning used in behavior analysis) app, and as such we aim to develop it like a' pharmaceutical vaccine'. This means first we target the ones who are really at the highest level of embracing it and at absolute need, and then focus on enlarging patients populations. 1st target group: Patients who undergo bariatric and metabolic surgery for their weight loss and because of comorbidities, like T2 diabetes, hypertension, and other factors of metabolic syndrome. 2nd target group: Patients pre-operative, waiting to be operated, or who will not be operated, because healthcare limitations , geographical restrictions ( in North Ireland f.ex. there are not any bariatric and metabolic operations taking place so people must go to England), financial burden for people themselves, and also fear of getting operated because they are not fully aware of the benefits and also because some of them cannot due to mental illness. 3rd target group: Post-infarction patients who must adopt new healthy eating and lifestyle behavioral changes

Solution & Product

One of the most effective long-term treatments for obesity is bariatric surgery. The surgery itself represents the first stage of what needs to be a lifelong adjustment of eating behaviour. Bariatric patients have specific needs that are vital to address in order to increase chances of long-term success with weight management after surgery. MyHabeats uses the power of self-monitoring, virtual interaction, & gamification to help post-operative patients embark on an individual journey providing personalized reminders, feedback and progress on healthy eating and lifestyle habits that last.

Innovation & Scalability

MyHabeats is tailored specifically to this population. Our solution is unique based on : 1: we target a vulnerable and marginalized population for which there is no other alternative for improved healthcare post surgery, although the healthcare practitioners recognize the need for such solutions ( Prof. Marin Fried cites that 30% success depends on surgery, 70% on behavioral changes) 2. we base our intervention on behavioral science which is proven for being an effective tool for long term lifestyle MyHabeats is the first behavioral vaccine ( a meaning used in behavior analysis) app, and as such we aim to develop it like a' pharmaceutical vaccine'. This means first we target the ones who are really at the highest level of embracing it and at absolute need, and then focus on enlarging patients populations. 1st target group: Patients who undergo bariatric and metabolic surgery for their weight loss and because of comorbidities, like T2 diabetes, hypertension, and other factors of metabolic syndrome. 2nd target group: Patients pre-operative, waiting to be operated, or who will not be operated, because healthcare limitations , geographical restrictions ( in North Ireland f.ex. the changes 3. we have based our design not only on behavioral science, and physicians recommendations but on our patients feedback from the previous versions we built: MVP, a-version, beta version and then final version 4. Network connection, expertise, and passion are not easily replicated. Meaning!

Traction & achievements

MyHabeats is the first behavioral vaccine ( a meaning used in behavior analysis) app, and as such we aim to develop it like a' pharmaceutical vaccine'. This means first we target the ones who are really at the highest level of embracing it and at absolute need, and then focus on enlarging patients populations. 1. already more than 600 users, license agreements 2. Initiate a clinical pilot study with Imperial College, NHS trust 3. Initiate a pilot at Czech Republic and AT 4. Avaiable in 6 languages 5. Award winners twice by EIT HEALTH 6. Incubated in the most renowned accelerator SmiLe at Lund Sweden 7. Member of the Health Tech Nordic community

Team & Why Us

Operations: Katie Milioni, founder&CEO, Thomas de Moor CTO Advisory Board &Experts :Dr Katerina Dounavi, Behaviour Analysisi, Lecturer Queen's University Belfast, Ass.Prof. K. Albanopoulos Bariatric Surgeon, University Hospital Ippocration, Prof. M.Fried Bariatric surgeon IFSO-EC executive member, Dir. Obesity Clinic Czech Republic. Patient Advocate Group

Funding Needs

MyHabeats is currently fundraising: The ASK: 500k euros to be allocated: 1: to further improve our product and embed AI on it based on feedback and our own research 2: Finalize our pilot studies 3: Invest on international business development, sales and marketing by investing also in enlarging our team